期刊文献+

基于临床常用指标建立急性髓系白血病死亡风险模型 被引量:6

Establishment of death risk model for acute myeloid leukemia based on conventional clinical indexes
原文传递
导出
摘要 目的应用临床常规指标建立急性髓系白血病(acute myelocytic leukemia,AML)死亡风险模型,为AML患者预后判断提供参考。方法回顾性分析165例AML患者的临床资料,以5a生存情况为结果变量,对可能影响预后的因素进行Cox比例风险回归分析,建立死亡风险模型。结果单变量Cox比例风险回归显示,年龄>60岁、体能状态评分高、确诊时外周血白细胞计数>50×109/L、放弃治疗、诱导治疗(柔红霉素+阿糖胞苷方案)4周失败及姑息治疗增加5a死亡风险,确诊时血红蛋白>80g/L是预后的保护因素;多因素Cox比例风险回归显示,年龄(RR=1.872)、体能状态评分(RR=1.269)、确诊时血红蛋白(RR=0.585)、外周血白细胞计数(RR=1.838)和治疗方案(RR=1.651)是影响预后的独立因素,死亡风险模型:h(t,X)/h0(t)=Exp(0.627年龄+0.238体能状态评分-0.536血红蛋白+0.609白细胞计数+0.501治疗方案);此模型预测死亡的AUC为0.867,大于年龄(0.725)、血红蛋白(0.698)、体能状态评分(0.682)、白细胞计数(0.634)和治疗方案(0.587)。结论以年龄、血红蛋白、体能状态评分、白细胞计数和治疗方案建立的死亡风险模型可为AML预后提供中等强度的诊断能力。 Objective To establish death risk model for acute myeloid leukemia(AML)based on conventional clinical indexes in order to provide references for predicting the prognosis of the patients with AML.Methods The clinical data of 165 patients with AML were retrospectively analyzed.Cox’s proportional hazard regression analysis was used to select influencing factors for prognosis,with 5-year survival as variable,and to establish death risk model.Results Univariate Cox’s proportional hazard regression analysis showed that age〉60years,high performance status score,peripheral white blood cell counts 〉50×109/L at the diagnosis of AML,abandoning treatment,failure of inductive treatment with daunorubicin plus cytarabin for 4weeks,and palliative treatment increased the 5-year death risk for patients with AML.And hemoglobin 〉80g/L at the diagnosis of AML was a protective factor for the prognosis.Multivariable Cox’s proportional hazard regression analysis showed that the age(RR=1.872),physical performance status score(RR=1.269),hemoglobin level at diagnosis(RR=0.585),peripheral white blood cell counts(RR=1.838)and treatment scheme(RR=1.651)were the independent factors for the prognosis.The death risk model was that h(t,X)/h0(t)=Exp(0.627age+0.238 performance status score-0.536hemoglobin+0.609 white blood cell counts+0.501 treatment scheme).By using the model for the prognosis of death,AUC was 0.867,larger than the age(0.725),hemoglobin(0.698),physical performance status score(0.682),white blood cell counts(0.634)and treatment scheme(0.587).Conclusion The death risk model established with covariates of age,hemoglobin,performance status score,white blood cell counts and treatment scheme can provide diagnostic value for the prognosis of AML.
出处 《中华实用诊断与治疗杂志》 2014年第11期1083-1085,共3页 Journal of Chinese Practical Diagnosis and Therapy
关键词 急性髓系白血病 预后 Cox比例风险回归 Acute myeloid leukemia prognosis Cox’s proportional hazard regression
  • 相关文献

参考文献6

二级参考文献74

  • 1秘营昌,陈雪晶,俞文娟,薛艳萍,赵耀忠,姜波,李大鹏,施均,卞寿庚,王建祥.原发性老年急性髓系白血病的特点及疗效分析[J].中华血液学杂志,2005,26(7):439-440. 被引量:4
  • 2邵彬,高彦荣,王椿,颜式可,蔡琦,姜杰玲,杨隽,白海涛,赵旻,赵初娴.77例老年急性髓性白血病患者的预后因素分析[J].癌症,2006,25(8):1007-1012. 被引量:7
  • 3Laubach J, Rao AV. Current and emerging strategies for the management of acute myeloid leukemia in the elderly[J]. Oncologist, 2008,13 (10) : 1097.
  • 4Kantarjian H,O'brien S, Cortes J, et al. Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome[J].Cancer, 2006,106 (3) : 1090.
  • 5Grimwade D,Walker H, Harrison G, et al. The predictive value of hierarchical eytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial[J]. Blood, 2001,98 (5) : 1312.
  • 6Craig CM,Schiller GJ. Acute myeloid leukemia in the elderly: conventional and novel treatment approaches[J].Blood Rev,2008,22(4):221.
  • 7Larson RA, Stone RM, Mayer RJ, et al. Fifty years of clinical research by the leukemia committee of the cancer and leukemia group B[J].Clin Cancer Res,2006,12(11):3556s.
  • 8Appelbaum FR,Gundaeker H, Head DR, et al. Age and acute myeloid leukemia[J]. Blood, 2006,107 (9) : 3481.
  • 9Menzin J, Lang K, Earle CC, et al. The outcomes and costs of acute myeloid leukemia among the elderly[J]. Arch Intern Med, 2002,162(14) : 1597.
  • 10Jehn U, Suciu S, Thomas X, et al. Non-infusional vs intravenous consolidation chemotherapy in elderly patients with acute myeloid leukemia, final results of the EORTCGIMEMA AML-13 randomized phase Ⅲ trial[J]. Leukemia,2006,20(10):1723.

共引文献28

同被引文献49

  • 1李纲.急性早幼粒细胞白血病20例诊断与治疗[J].中国实用医刊,2010,37(10):69-69. 被引量:4
  • 2Tarraga Lopez PJ, Albert) JS, Rodriquez-Montes JA. Primary and sec-ondary prevention of colorectal cancer[ J]. Clin Med Insights Gastroen-terol,2014,7 :33-46.
  • 3Timme CR,Gruidl M,Yeatman TJ. Gamma-secretase inhibition attenu-ates oxaliplatin-induced apoptosis through increased Mcl-1 and/or Bcl-xL in human colon cancer cells[ J]. Apoptosis,2013 ,18(10) : 1163-1174.
  • 4Sun JG,Xiang J,Zeng XL, et al. Clitocine induces apoptosis and en-hances the lethality of ABT-737 in human colon cancer cells by disrup-ting the interaction of Mcl-1 and Bak[ J] . Cancer Lett,2014,355(2):253-263.
  • 5Mhaidat NM,Alzoubi KH,Al-Azzam SI,et al. Caffeine inhibits paclita-xel induced apoptosis in colorectal cancer cells through the upregula-tion of Mcl 1 levels [J]. Mol Med Rep,2014,9( 1) :243-248.
  • 6Ertel F, Nguyen M, Roulston A, et al. Programming cancer cells forhigh expression levels of Mcll [ J]. EMBO Rep,2013,14(4) :328-336.
  • 7Craig RW. MCL1 provides a window on the role of the BCL2 family incell proliferation,differentiation and tumorigenesis [ J ] . Leukemia,2002,16(4) :444454.
  • 8Lee WS,Park YL, Kim N, et al. Myeloid cell leukemia-1 is associatedwith tumor progression by inhibiting apoptosis and enhancing angio-genesis in colorectal cancer[ J] . Am J Cancer Res,2014,5(1): 101-113.
  • 9Hernandez JM,Farma JM,Coppola D,et al. Expression of the anti-apoptotic protein survivin in colon cancer[ J]. Clin Colorectal Canc-er,2011,10(3) :188-193.
  • 10Eichhom JM, Alford SE, Sakurikar N, et al. Molecular analysis offunctional redundancy among anti-apoptotic Bcl-2 proteins and itsrole in cancer cell survival[ J]. Exp Cell Res,2014,322(2) :415-424.

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部